Home Newsfeeds Loop Capital Downgrades Altra Industrial Motion to Hold, Announces $62 Price Target

Loop Capital Downgrades Altra Industrial Motion to Hold, Announces $62 Price Target

Loop Capital analyst Scott Graham downgrades Altra Industrial Motion (NASDAQ:AIMC) from Buy to Hold and announces $62 price target.

byBenzinga Newsdesk

March 3, 2023

1 minute read

Loop Capital analyst Scott Graham downgrades Altra Industrial Motion (NASDAQ:AIMC) from Buy to Hold and announces $62 price target.

Aethlon Medical Announces Appointment Of James B. Frakes, M.B.A. As Interim Chief Executive Officer And Guy Cipriani, M.B.A. As Chief Operating Officer

By Benzinga Newsdesk

November 13, 9:38 AM

Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that James B. Frakes, M.B.A., Chief

AEMD

SP Plus Q2 EPS $0.42 Misses $0.67 Estimate

By Benzinga Newsdesk

August 3, 5:13 PM

SP Plus (NASDAQ:SP) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.67 by 37.31 percent. This is a 14.29 percent decrease over earnings of $0.49 per share from the same

Matinas BioPharma Provides Business Update And 2023 Strategic Outlook; Ended 2022 With ~$28.8M, Sufficient To Fund Planned Operations Into Q2 2024

By Happy Mohamed

January 30, 5:04 PM

2022 Success Has Increased Confidence to Focus LNC Delivery Platform on the Future of Medicine - Delivering Genes Prioritization on Building External Partnerships and an Internal Pipeline Centered on Gene

MTNB

Elon Musk Mocks Steve Jobs, Apple’s Potential Deal With OpenAI, Siri’s AI Overhaul And More: This Week In Appleverse

By Benzinga Neuro

June 2, 8:30 AM

The past week has been a rollercoaster ride in the tech world, with Elon Musk taking a dig at Apple Inc., Apple's reported deal with OpenAI, and the tech giant's plans to revamp Siri. Let's dive into the details.

AAPL

Loop Capital Downgrades Altra Industrial Motion to Hold, Announces $62 Price Target

Related Posts

Aethlon Medical Announces Appointment Of James B. Frakes, M.B.A. As Interim Chief Executive Officer And Guy Cipriani, M.B.A. As Chief Operating Officer

SP Plus Q2 EPS $0.42 Misses $0.67 Estimate

Matinas BioPharma Provides Business Update And 2023 Strategic Outlook; Ended 2022 With ~$28.8M, Sufficient To Fund Planned Operations Into Q2 2024

Elon Musk Mocks Steve Jobs, Apple’s Potential Deal With OpenAI, Siri’s AI Overhaul And More: This Week In Appleverse